Lytix Biopharma has appointed Gry Stensrud as Chief Technology Officer
Lytix Biopharma is happy to announce that as of today, March 1st 2021, Gry Stensrud will join the management team and work as the company’s Chief Technology Officer. As the CTO, she will provide strategic, tactical and technical expertise and oversight of all CMC-related activities to support company product development from preclinical stage through clinical and commercial phases in compliance with all regulatory and quality requirements.
Stensrud has more than 20 years expertise in research, development, clinical trials, manufacturing and distribution of medicinal products and medical devices as well as extensive leadership experience and former experience in developing a Biotech company.
Prior to joining Lytix, Dr. Stensrud was Vice President Technical Development & Operations at Photocure.
We are delighted to have Gry joining Lytix. She brings with her valuable experience within CMC and biotech leadership and will be a great addition to our team and the company, says Øystein Rekdal, CEO in Lytix Biopharma.